Search

everythinglearnresearchcommunity

for

Search:↓

Higher CRBP1 levels are linked to more severe alopecia areata.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Psychological stress is a major factor in the onset and severity of alopecia areata, with atopic individuals being more prone to develop it.

Higher levels of retinol-binding protein 4 are found in people with alopecia areata, but these levels don't relate to how severe the condition is.

Men with higher body mass index (BMI) in Taiwan tend to have more severe hair loss.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.

The study concluded that yellow dots are a common and useful sign for diagnosing alopecia areata in dark-skinned individuals and may indicate the severity of the condition.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

People with alopecia areata often have lower vitamin D levels, which may be linked to the condition's severity.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

People with Alopecia areata often have lower vitamin D levels, which may be linked to the severity of their condition.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Certain gene variations may increase the risk and severity of alopecia areata.

The rs231775 genetic variant is linked to a higher risk and severity of Alopecia Areata in males.

Low levels of zinc and ferritin may be linked to the severity of alopecia areata in Iraqi patients.

Human Beta Defensin 1 levels do not predict the risk or severity of Alopecia Areata.

People with Alopecia areata often have lower Vitamin D levels, which might affect the severity of their condition.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Certain daily habits like stress, diet, and sleep can affect the severity of hair loss in alopecia areata.

The conclusion is that in the Indian subcontinent, socioeconomic status, stress, and family structure affect the severity of alopecia areata, and its psychological impact is generally mild or moderate.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Trichoscopy is crucial for diagnosing and managing androgenetic alopecia, showing increased vellus hairs, empty follicles, and fibrosis with severity.

Alopecia areata and androgenetic alopecia affect quality of life similarly.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Tofacitinib may help treat severe hair loss, but more research is needed.

Baricitinib is effective and safe for treating severe alopecia areata.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.